Committee members and all investigators are reported in Supporting Information Appendix A.
Prospective European Survey on Atrial Fibrillation Ablation: Clinical Characteristics of Patients and Ablation Strategies Used in Different Countries
Version of Record online: 8 JUL 2014
© 2014 Wiley Periodicals, Inc.
Journal of Cardiovascular Electrophysiology
Volume 25, Issue 10, pages 1074–1081, October 2014
How to Cite
THEMISTOCLAKIS, S., RAVIELE, A., CHINA, P., PAPPONE, C., PONTI, R. D., REVISHVILI, A., ALIOT, E., KUCK, K.-H., HOFF, P. I., SHAH, D., ALMENDRAL, J., MANOLIS, A. S., CHIERCHIA, G.-B., OTO, A., VATASESCU, R. G., SINKOVEC, M., CAPPATO, R. (2014), Prospective European Survey on Atrial Fibrillation Ablation: Clinical Characteristics of Patients and Ablation Strategies Used in Different Countries. Journal of Cardiovascular Electrophysiology, 25: 1074–1081. doi: 10.1111/jce.12462
The task of producing the present survey was committed by the European Cardiac Arrhythmia Society (ECAS) to a group of independent electrophysiology experts who would serve on behalf of ECAS to generate the requested information. The work was made possible by a research grant from Biosense Webster, part of Johnson & Johnson family of companies.
S. Themistoclakis reports participation on a research grant supported by Biosense Webster and serving as a consultant/advisory board member for the company. R. De Ponti reports compensation for participation on a speakers’ bureau and serving as a consultant/advisory board member for Biosense Webster. E. Aliot reports consulting for Meda, Sanofi-Aventis, Boehringer Ingelheim, Pfizer/BMS, GlaxoSmithKline. D. Shah reports participation on research grants supported by Biosense Webster, St. Jude Medical, and Bard. J. Almendral reports honoraria relevant to this study from Medtronic and St. Jude Medical. G-B Chierchia reports honoraria relevant to this topic from Biosense Webster, Medtronic, AF Solutions, and serving on advisory boards of Medtronic and AF Solutions. R. Cappato reports participation on research grants and other research support, but did not specify the entity. Other authors: No disclosures.
- Issue online: 10 OCT 2014
- Version of Record online: 8 JUL 2014
- Accepted manuscript online: 2 JUN 2014 03:34AM EST
- Manuscript Accepted: 13 MAY 2014
- Manuscript Revised: 29 APR 2014
- Manuscript Received: 19 MAY 2013
- Biosense Webster, part of Johnson & Johnson family of companies
Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.
Appendix A: Steering Committee Members and National Coordinators. Participating Centers and Investigators.
Appendix B: Case Identification Questionnaire. To be performed for each patient at time of the AFib ablation procedure.
Appendix C: Questionnaire on the AFib Ablation Procedure. To be performed for each patient at time of the AFib ablation procedure.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.